Locke Imogen, Mitchell Gillian, Eeles Rosalind
Translational Cancer Genetics Team & Cancer Genetics Unit, The Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, Surrey, UK.
Breast Cancer Res. 2004;6(2):75-81. doi: 10.1186/bcr759. Epub 2004 Jan 26.
The ductal approach to breast cancer, encompassing nipple aspiration, ductal lavage and duct endoscopy, allows assessment of breast ductal epithelial cells and their local microenvironment in a graded process of increasing invasiveness. Samples of ductal epithelial cells sufficient for cytological diagnosis may be safely collected, titres of individual proteins showing variation with breast cancer status may be measured, and abnormal pathology within the breast ducts may be directly visualized. Identification of surrogate molecular markers may facilitate early breast cancer detection, in conjunction with cytological assessment, and be useful for individual prediction of breast cancer risk and assessment of treatment response. However, the sensitivity and specificity of the ductal approach require further evaluation. The small quantities of nipple aspiration fluid available for analysis, and difficulties identifying and cannulating ducts remain important limitations of these techniques.
乳腺癌的导管检查方法,包括乳头抽吸、导管灌洗和导管内镜检查,能够在侵入性逐渐增加的分级过程中评估乳腺导管上皮细胞及其局部微环境。可以安全地采集足以进行细胞学诊断的导管上皮细胞样本,测量显示随乳腺癌状态而变化的个体蛋白质水平,并且可以直接观察乳腺导管内的异常病理情况。与细胞学评估相结合,替代分子标志物的识别可能有助于早期乳腺癌的检测,并且对于个体乳腺癌风险预测和治疗反应评估有用。然而,导管检查方法的敏感性和特异性需要进一步评估。可用于分析的乳头抽吸液量少,以及导管识别和插管困难仍然是这些技术的重要局限性。